AFCM
PFE icon

Applied Finance Capital Management’s Pfizer PFE Stock Holding History

Applied Finance Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$947K Sell
39,346
-7,289
-16% -$191K 0.07% 109
2026
Q1 		$1.31M Buy
46,635
+4,723
+11% +$126K 0.1% 85
2025
Q4 		$1.04M Sell
41,912
-20,143
-32% -$508K 0.07% 98
2025
Q3 		$1.58M Sell
62,055
-9,164
-13% -$226K 0.11% 74
2025
Q2 		$1.73M Buy
+71,219
New +$1.66M 0.12% 77
2024
Q1 		– Sell
-457,366
Closed -$13.2M – 77
2023
Q4 		$13.2M Buy
457,366
+47,593
+12% +$1.44M 1.14% 47
2023
Q3 		$13.6M Buy
409,773
+85,405
+26% +$3.02M 1.48% 44
2023
Q2 		$11.9M Buy
324,368
+22,708
+8% +$884K 1.35% 45
2023
Q1 		$12.3M Buy
301,660
+3,305
+1% +$143K 1.53% 37
2022
Q4 		$15.3M Buy
+298,355
New +$14.3M 1.99% 18

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Applied Finance Capital Management's PFE Position: Q2 2026 in Review

Applied Finance Capital Management reduced its Pfizer (PFE) stake by 16% in Q2 2026, selling an estimated $191K and leaving 39,346 shares worth $947K. The position accounts for 0.07% of the portfolio, ranked #109.

Applied Finance Capital Management first reported a position in PFE in Q4 2022 and has held it in 10 quarters since. The position peaked at $15.3M in Q4 2022. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Applied Finance Capital Management held 39,346 shares of Pfizer worth $947K as of Q2 2026.
  • Applied Finance Capital Management sold 7,289 Pfizer shares in Q2 2026, an estimated $191K.
  • Pfizer made up 0.07% of Applied Finance Capital Management's portfolio in Q2 2026, its #109 holding.
  • Applied Finance Capital Management first reported a position in Pfizer in Q4 2022 and has held it in 10 quarters since.
  • Applied Finance Capital Management's Pfizer position peaked at $15.3M in Q4 2022.
  • 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Applied Finance Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.